Publicacións en colaboración con investigadores/as de Centro Nacional de Epidemiología (10)

2021

  1. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

  2. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252

2020

  1. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536

  2. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

    The Lancet, Vol. 396, Núm. 10250, pp. 535-544

2017

  1. FIRST CASES OF SEVERE FLACCID PARALYSIS ASSOCIATED WITH ENTEROVIRUS D68 INFECTION IN SPAIN, 2015–2016

    Pediatric Infectious Disease Journal, Vol. 36, Núm. 12, pp. 1214-1216

2014

  1. Clinically relevant transmitted drug resistance to first line antiretroviral drugs and implications for recommendations

    PLoS ONE, Vol. 9, Núm. 3

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

  2. Genetic diversity of influenza A(H1N1)2009 virus circulating during the season 2010-2011 in Spain

    Journal of Clinical Virology, Vol. 53, Núm. 1, pp. 16-21

2010

  1. Incidencia y factores de riesgo de gastroenteritis en los peregrinos del Camino de Santiago durante el verano de 2008 en el camino francés

    Gaceta Sanitaria, Vol. 24, Núm. 6, pp. 487-490

2009

  1. HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations

    Journal of Antimicrobial Chemotherapy, Vol. 64, Núm. 2, pp. 251-258